Eli Lilly and Company, a pharmaceutical company based in Indianapolis, Indiana, revealed it has teamed up with Amazon Pharmacy to help deliver its Zepbound weight loss drug and other medicines straight to customers' homes.
It struck a partnership deal with the online pharmacy subsidiary of Amazon Inc. just four months after obtaining the required regulatory approval to sell its diabetes treatment under a different name and category: weight loss.
Lilly's Weight Loss Treatment
According to CBS News, Eli Lilly's Tirzepatide drug, currently sold as a Mounjaro brand for diabetes, is now on the market under the new name Zepbound. It is also advertised as a weight-loss medication administered using an injection pen.
The company reportedly started selling Zepbound earlier this year. The drugs are directly sold to patients. Patients consult with doctors and obtain prescriptions from digital pharmacies, and the drugs are delivered to them.
Amazon Pharmacy Added as Home Delivery Option
Its partnership with Amazon's pharmacy unit allows patients and customers to obtain their medications quickly. In addition to Amazon Pharmacy, Eli Lilly delivers drugs to its customers via Truepill.
"Lilly has selected Amazon Pharmacy as a dispensing pharmacy option, allowing patients to receive fast, free delivery of medications and 24/7 access to clinical pharmacists," Dr. Vin Gupta, Amazon Pharmacy's chief medical officer, said in a press release. "To help patients being treated for diabetes, obesity, and migraine, Amazon Pharmacy is now offering home delivery of select medications through LillyDirect."
Dr. Gupta added, "Lilly has selected Amazon Pharmacy to serve as a third-party dispensing provider for LillyDirect Pharmacy Solutions, delivering prescribed Lilly medications directly to a patient's home."
Photo by: James Yarema/Unsplash


Lululemon Founder Chip Wilson Escalates Proxy Fight to Remove Advent From Board
Morgan Stanley Flags High Volatility Ahead for Tesla Stock on Robotaxi and AI Updates
Global DRAM Chip Shortage Puts Automakers Under New Cost and Supply Pressure
OpenAI Launches Stargate Community Plan to Offset Energy Costs and Support Local Power Infrastructure
Memory Chip Shortage Drives Higher Gadget Prices and Weakens Global Tech Demand
Renault Group Global Sales Rise 3.2% in 2025 on Strong International and EV Demand
FAA Says It Is Not Blocking Boeing 737 MAX 7 and MAX 10 Certification
Netflix Stock Slips After Earnings as Soft 2026 Guidance Overshadows Subscriber Milestone
Pop Mart Shares Surge in Hong Kong After First Buyback in Nearly Two Years
Court Allows Expert Testimony Linking Johnson & Johnson Talc Products to Ovarian Cancer
U.S. Vaccine Policy Shifts Under RFK Jr. Create Uncertainty for Pharma and Investors
Walmart to Cut PhonePe Stake in IPO as Tiger Global and Microsoft Exit
Valentino Garavani Dies at 93, Leaving Behind the Timeless Legacy of Valentino Red
SoftBank Shares Surge as AI Optimism Lifts Asian Tech Stocks
BitGo IPO Prices Above Range, Raises $212.8M in Landmark Crypto Market Debut
Lynas Rare Earths Shares Surge as Quarterly Revenue Jumps on Strong Prices 



